Targeted NIR-II Photothermal Therapy Enabled by Bioorthogonal Click Reaction With Olympicenyl Radical Nanoparticles.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 42604444.
- Also identified by DOI 10.1002/adhm.71597.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study presents an application of delocalized hydrocarbon neutral monoradical, an olympicenyl radical (OR6), as a high-performance organic photothermal agent (PTA) for targeted photothermal therapy (PTT). By encapsulating OR6 into functionalized nanoparticles (dOR6-NPs), a remarkable near-infrared-II (NIR-II) absorption at 1056 nm and photothermal conversion efficiency (PCE) of 84.66% are achieved. To overcome the limitations of passive tumor targeting, a bioorthogonal "tag-and-target" strategy is developed using metabolic glycan labeling and copper-free click reaction. This approach significantly enhanced photothermal therapeutic efficacy both in vitro and in vivo. The dOR6-NPs induce significant cytotoxicity of cancer cells under 1064 nm laser irradiation, leading to nearly complete tumor suppression in a xenograft model while maintaining excellent biocompatibility and systemic safety. This work not only highlights olympicenyl radicals as a new class of PTAs but also establishes a robust click-reaction-based platform for precision cancer therapy.